The clinical significance of hypoxia in human cancers
N Dhani, A Fyles, D Hedley, M Milosevic - Seminars in nuclear medicine, 2015 - Elsevier
Hypoxia is present to some extent in most solid malignant human cancers because of an
imbalance between the limited oxygen delivery capacity of the abnormal vasculature and …
imbalance between the limited oxygen delivery capacity of the abnormal vasculature and …
Inflammation as a driver of prostate cancer metastasis and therapeutic resistance
M Archer, N Dogra, N Kyprianou - Cancers, 2020 - mdpi.com
Simple Summary Prostate cancer is the most common malignancy in men, with a high
mortality rate when disease progresses to metastasis and therapeutic resistance. Evidence …
mortality rate when disease progresses to metastasis and therapeutic resistance. Evidence …
Functional immune cell‐derived exosomes engineered for the trilogy of radiotherapy sensitization
X Ma, M Yao, Y Gao, Y Yue, Y Li, T Zhang… - Advanced …, 2022 - Wiley Online Library
The limited efficacy of radiotherapy leads to radio‐resistance and high rates of tumor
recurrence and metastasis, which is caused by tumor hypoxia, rapid DNA damage repair …
recurrence and metastasis, which is caused by tumor hypoxia, rapid DNA damage repair …
Molecular imaging–based dose painting: A novel paradigm for radiation therapy prescription
SM Bentzen, V Gregoire - Seminars in radiation oncology, 2011 - Elsevier
Dose painting is the prescription of a nonuniform radiation dose distribution to the target
volume based on functional or molecular images shown to indicate the local risk of relapse …
volume based on functional or molecular images shown to indicate the local risk of relapse …
Tumor hypoxia predicts biochemical failure following radiotherapy for clinically localized prostate cancer
Purpose: Tumor hypoxia is an important determinant of outcome in many human
malignancies and is associated with treatment resistance and metastases. The aim of this …
malignancies and is associated with treatment resistance and metastases. The aim of this …
Oxygen-enhanced MRI accurately identifies, quantifies, and maps tumor hypoxia in preclinical cancer models
JPB O'Connor, JKR Boult, Y Jamin, M Babur… - Cancer research, 2016 - AACR
There is a clinical need for noninvasive biomarkers of tumor hypoxia for prognostic and
predictive studies, radiotherapy planning, and therapy monitoring. Oxygen-enhanced MRI …
predictive studies, radiotherapy planning, and therapy monitoring. Oxygen-enhanced MRI …
[HTML][HTML] Anthracycline chemotherapy inhibits HIF-1 transcriptional activity and tumor-induced mobilization of circulating angiogenic cells
Using a cell-based reporter gene assay, we screened a library of drugs in clinical use and
identified the anthracycline chemotherapeutic agents doxorubicin and daunorubicin as …
identified the anthracycline chemotherapeutic agents doxorubicin and daunorubicin as …
Cancer–stromal cell interactions mediated by hypoxia-inducible factors promote angiogenesis, lymphangiogenesis, and metastasis
GL Semenza - Oncogene, 2013 - nature.com
Interactions between cancer cells and stromal cells, including blood vessel endothelial cells
(BECs), lymphatic vessel endothelial cells (LECs), bone marrow-derived angiogenic cells …
(BECs), lymphatic vessel endothelial cells (LECs), bone marrow-derived angiogenic cells …
Hypoxia-induced exosome secretion promotes survival of African-American and Caucasian prostate cancer cells
African American men in the United States have higher mortality due to prostate cancer
(PCa) compared to other races. One reason for this disparity is the lack of in-depth …
(PCa) compared to other races. One reason for this disparity is the lack of in-depth …
Bringing the heavy: carbon ion therapy in the radiobiological and clinical context
Radiotherapy for the treatment of cancer is undergoing an evolution, shifting to the use of
heavier ion species. For a plethora of malignancies, current radiotherapy using photons or …
heavier ion species. For a plethora of malignancies, current radiotherapy using photons or …